Haloprogin is used as a topical ointment or cream in the treatment of Tinea infections. Tinea infections are superficial fungal infections caused by three species of fungi collectively known as dermatophytes (Trichophyton, Microsporum and Epidermophyton). Commonly these infections are named for the body part affected, including tinea corporis (general skin), tinea cruris (groin), and tinea pedis (feet). Haloprogin is a halogenated phenolic ether administered topically for dermotaphytic infections. The mechanism of action is unknown, but it is thought to be via inhibition of oxygen uptake and disruption of yeast membrane structure and function. Haloprogin is no longer available in the United States and has been discontinued.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Dicoumarol | The therapeutic efficacy of Dicoumarol can be increased when used in combination with Haloprogin. |
| Phenindione | The therapeutic efficacy of Phenindione can be increased when used in combination with Haloprogin. |
| Warfarin | The therapeutic efficacy of Warfarin can be increased when used in combination with Haloprogin. |
| Phenprocoumon | The therapeutic efficacy of Phenprocoumon can be increased when used in combination with Haloprogin. |
| Acenocoumarol | The therapeutic efficacy of Acenocoumarol can be increased when used in combination with Haloprogin. |
| 4-hydroxycoumarin | The therapeutic efficacy of 4-hydroxycoumarin can be increased when used in combination with Haloprogin. |
| Coumarin | The therapeutic efficacy of Coumarin can be increased when used in combination with Haloprogin. |
| (R)-warfarin | The therapeutic efficacy of (R)-warfarin can be increased when used in combination with Haloprogin. |
| Ethyl biscoumacetate | The therapeutic efficacy of Ethyl biscoumacetate can be increased when used in combination with Haloprogin. |
| Fluindione | The therapeutic efficacy of Fluindione can be increased when used in combination with Haloprogin. |
| Clorindione | The therapeutic efficacy of Clorindione can be increased when used in combination with Haloprogin. |
| Diphenadione | The therapeutic efficacy of Diphenadione can be increased when used in combination with Haloprogin. |
| Tioclomarol | The therapeutic efficacy of Tioclomarol can be increased when used in combination with Haloprogin. |
| (S)-Warfarin | The therapeutic efficacy of (S)-Warfarin can be increased when used in combination with Haloprogin. |